Clinical Trial Update: A Study of Sepiapterin in Participants With Phenylketonuria (PKU) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial investigating sepiapterin for phenylketonuria is currently recruiting participants.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Phenylketonuria

Drugs mentioned

• Sepiapterin (sepiapterin)

Snippet

Sponsor: PTC Therapeutics | Conditions: Phenylketonuria | Phase 3 | Status: RECRUITING